Is there value in kinetic modeling of thrombin generation? No (unless...)

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 8, 2012, Pages 1470-1477

  Hemker, H C ^a   Kerdelo, S ^b   Kremers, R M W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Diagnostica Stago   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; MELAGATRAN; PROTHROMBIN; THROMBIN;

ARTICLE; CHEMICAL REACTION; COMPUTER SIMULATION; CONCENTRATION (PARAMETERS); DRUG MECHANISM; HEMOPHILIA; INHIBITION KINETICS; LABORATORY TEST; MATHEMATICAL MODEL; MOLECULAR MODEL; PREDICTIVE VALUE; PRIORITY JOURNAL; STANDARDIZATION; THROMBOCYTE; THROMBOGENESIS;

ANIMALS; BLOOD COAGULATION; HUMANS; PARTIAL THROMBOPLASTIN TIME; THROMBIN;

EID: 84865222041     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04802.x     Document Type: Article

References (65)

1. Ataullakhanov FI, Guria GT, Sarbash VI, Volkova RI. Spatiotemporal dynamics of clotting and pattern formation in human blood. Biochim Biophys Acta 1998; 1425: 453-68.
2. Baldwin SA, Basmadjian D. A mathematical model of thrombin production in blood coagulation. Part I: The sparsely covered membrane case. Ann Biomed Eng 1994; 22: 357-70.
3. Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR. Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS One 2012; 7: e29178
4. Burghaus R, Coboeken K, Gaub T, Kuepfer L, Sensse A, Siegmund HU, Weiss W, Mueck W, Lippert J. Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation. PLoS One 2012; 6: e17626.
5. Butenas S, van't Veer C, Mann KG. 'Normal' thrombin generation. Blood 1999; 94: 2169-78.
6. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 2012; 6: e1000950.
7. Danforth CM, Orfeo T, Everse SJ, Mann KG, Brummel-Ziedins KE. Defining the boundaries of normal thrombin generation: investigations into hemostasis. PLoS One 2012; 7: e30385
8. Danforth CM, Orfeo T, Mann KG, Brummel-Ziedins KE, Everse SJ. The impact of uncertainty in a blood coagulation model. Math Med Biol 2009; 26: 323-36.
9. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-33.
10. Iliadis A, Cheruy A, Daver J, Desnoyers P. A model of the blood coagulation system. C R Acad Sci Hebd Seances Acad Sci D 1977; 284: 2411-14.
11. Jones KC, Mann KG. A model for the tissue factor pathway to thrombin II. A mathematical simulation. J Biol Chem 1994; 269: 23367-73.
12. Khanin MA, Semenov VV. A mathematical model of the kinetics of blood coagulation. J Theor Biol 1989; 136: 127-34.
13. Krasotkina YV, Sinauridze EI, Ataullakhanov FI. Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion. Biochim Biophys Acta 2000; 1474: 337-45.
14. Nesheim ME, Tracy RP, Mann KG. 'Clotspeed', a mathematical simulation of the functional properties of prothrombinase. J Biol Chem 1984; 259: 1447-53.
15. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, Vorob'ev AI, Ataullakhanov FI. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta 2002; 1572: 45-57.
16. Panteleev MA, Balandina AN, Lipets EN, Ovanesov MV, Ataullakhanov FI. Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation. Biophys J 2010; 98: 1751-61
17. Qiao YH, Liu JL, Zeng YJ. A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path. J Med Eng Technol 2005; 29: 70-4.
18. Qiao YH, Xu CQ, Zeng YJ, Xu XH, Zhao H, Xu H. The kinetic model and simulation of blood coagulation - the kinetic influence of activated protein C. Med Eng Phys 2004; 26: 341-7.
19. Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma. Biochim Biophys Acta 1998; 1425: 607-16.
20. Venkateswarlu D, Duke RE, Perera L, Darden TA, Pedersen LG. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study. J Thromb Haemost 2003; 1: 2577-88.
21. Willems GM, Lindhout T, Hermens WT, Hemker HC. Simulation model for thrombin generation in plasma. Haemostasis 1991; 21: 197-207.
22. Zarnitsina VI, Pokhilko AV, Ataullakhanov FI. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results. Thromb Res 1996; 84: 333-44.
23. Zarnitsina VI, Pokhilko AV, Ataullakhanov FI. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. I. The model description. Thromb Res 1996; 84: 225-36.
24. Popper KR. The Logic of Scientific Discovery. New York: Basic Books, 1959.
25. Wagenvoord R, Hemker PW, Hemker HC. The limits of simulation of the clotting system. J Thromb Haemost 2006; 4: 1331-8.
26. Bungay SD, Gentry PA, Gentry RD. A mathematical model of lipid-mediated thrombin generation. Math Med Biol 2003; 20: 105-29.
27. Panteleev MA, Balandina AN, Lipets EN, Ovanesov MV, Ataullakhanov FI. Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation. Biophys J 2010; 98: 1751-61.
28. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
29. Butenas S, Branda RF, van't Veer C, Cawthern KM, Mann KG. Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost 2001; 86: 660-7.
30. Orfeo T, Gissel M, Butenas S, Undas A, Brummel-Ziedins KE, Mann KG. Anticoagulants and the propagation phase of thrombin generation. PLoS One 2011; 6: e27852
31. Nagashima H. Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban II. Effects on fibrinolysis. J Biol Chem 2002; 277: 50445-9.
32. Al Dieri R, Bloemen S, Hemker HC. Activated clotting factor V inhibits tissue factor-initiated thrombin generation. J Thromb Haemost 2012; Under consideration.
33. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99: 923-30.
34. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997; 272: 4367-77.
35. Orfeo T, Butenas S, Brummel-Ziedins KE, Gissel M, Mann KG. Anticoagulation by factor Xa inhibitors. J Thromb Haemost 2010; 8: 1745-53
36. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
37. ten Cate-Hoek AJ, Dielis AW, Spronk HM, van Oerle R, Hamulyak K, Prins MH, ten Cate H. Thrombin generation in patients after acute deep vein thrombosis. Thromb Haemost 2008; 100: 240-5.
38. Hemker HC. Thrombin generation in a reconstituted system: a comment. Thromb Haemost 2002; 87: 551-4.
39. Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE. Thrombin generation and bleeding in haemophilia A. Haemophilia 2009; 15: 1118-25.
40. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 2005; 3: 2497-505.
41. Panteleev MA, Ananyeva NM, Ataullakhanov FI, Saenko EL. Mathematical models of blood coagulation and platelet adhesion: clinical applications. Curr Pharm Des 2007; 13: 1457-67.
42. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyak K, ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6: 125-31.
43. Adams TE, Everse SJ, Mann KG. Predicting the pharmacology of thrombin inhibitors. J Thromb Haemost 2003; 1: 1024-7.
44. Wagenvoord RJ, Deinum J, Elg M, Hemker HC. The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha-macroglobulin-thrombin. J Thromb Haemost 2010; 8: 1281-9.
45. Ataullakhanov FI, Guriia GT, Safroshkina A. Spatial aspects of the dynamics of blood coagulation II. Phenomenological model. Biofizika 1994; 39: 97-106.
46. Zarnitsina VI, Ataullakhanov FI, Lobanov AI, Morozova OL. Dynamics of spatially nonuniform patterning in the model of blood coagulation. Chaos 2001; 11: 57-70.
47. Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate. J Thromb Haemost 2005; 3: 321-31.
48. Rivard GE, Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3: 2039-43
49. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
50. Uzome M, Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood 2008; 111: 3507-3513.
51. Wajima T, Isbister GK, Duffull SB. A comprehensive model for the humoral coagulation network in humans. Clin Pharmacol Ther 2009; 86: 290-8.
52. Zhu D. Mathematical modeling of blood coagulation cascade: kinetics of intrinsic and extrinsic pathways in normal and deficient conditions. Blood Coagul Fibrinolysis 2007; 18: 637-46.
53. Xu C, Hu Xu X, Zeng Y, Wen Chen Y. Simulation of a mathematical model of the role of the TFPI in the extrinsic pathway of coagulation. Comput Biol Med 2005; 35: 435-45.
54. Nagashima H. Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban I. Effects on thrombin generation. J Biol Chem 2002; 277: 50439-44.
55. Xu CQ, Zeng YJ, Gregersen H. Dynamic model of the role of platelets in the blood coagulation system. Med Eng Phys 2002; 24: 587-93.
56. Lo K, Denney WS, Diamond SL. Stochastic modeling of blood coagulation initiation. Pathophysiol Haemost Thromb 2005; 34: 80-90.
57. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
58. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
59. Pusey ML, Nelsestuen GL. The physical significance of Km in the prothrombinase reaction. Biochem Biophys Res Commun 1983; 114: 526-32.
60. van Rijn JL, Govers-Riemslag JW, Zwaal RF, Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 1984; 23: 4557-64.
61. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
62. Krishnaswamy S, Church WR, Nesheim ME, Mann KG. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987; 262: 3291-9.
63. Giesen PL, Willems GM, Hermens WT. Production of thrombin by the prothrombinase complex is regulated by membrane-mediated transport of prothrombin. J Biol Chem 1991; 266: 1379-82.
64. Willems GM, Giesen PL, Hermens WT. Adsorption and conversion of prothrombin on a rotating disc. Blood 1993; 82: 497-504.
65. Camire RM, Kalafatis M, Tracy PB. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding. Biochemistry 1998; 37: 11896-906